Kang, H., Lim, A., Clark, A.D., Colón-González, F.J., Clapham, H.E., Carrera, J.P., Kim, J., Auzenbergs, M., Preethi, L., López-Vergès, S., Sim, S.Y., Han, S.M., Silva, T.C., Endy, T., Cucunubá, Z., Edmunds, W.J., Sahastrabuddhe, S., and Brady, O.J., Abbas, K. Age-specific chikungunya outbreak response immunisation strategies in Brazil: a modelling study, eClinicalMedicine, https://doi.org/10.1016/j.eclinm.2025.103690
Kang, H., Lim, A., Auzenbergs, M., Clark, A., Colón-González, F.J., Salje, H., Clapham, H., Carrera, J.P., Kim, J.-H., Malarski, M., López-Vergès, S., Cucunubá, Z.M., Cerqueira-Silva, T., Edmunds, W.J., Sahastrabuddhe, S., Brady, O.J. and Abbas, K. (2025) ‘Global, regional and national burden of chikungunya: force of infection mapping and spatial modelling study’, BMJ Global Health, 10(10). https://doi.org/10.1136/bmjgh-2024-018598.
Kang H, Clark AD, Lim A, Colón-González FJ, Silva TC, Kim JH, Auzenbergs M, Bichha N, Arora NK, Sim SY, Vergès SL, Sahastrabuddhe S, Brady O, Abbas K. Benefit-Risk of the live-attenuated chikungunya vaccine Ixchiq for travel vaccination and age-specific outbreak response immunisation strategies: a modelling study. Available at SSRN: https://dx.doi.org/10.2139/ssrn.6441004
Kang, H., Auzenbergs, M., Clapham, H., Maure, C., Kim, J.-H., Salje, H., Taylor, C.G., Lim, A., Clark, A., Edmunds, W.J., Sahastrabuddhe, S., Brady, O.J. and Abbas, K. (2024) ‘Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study’, The Lancet Infectious Diseases, 24(5), pp. 488–503. https://doi.org/10.1016/S1473-3099(23)00810-1.
Auzenbergs, M., Maure, C., Kang, H., Clark, A., Brady, O., Sahastrabuddhe, S. and Abbas, K. (2024) ‘Programmatic considerations and evidence gaps for chikungunya vaccine introduction in countries at risk of chikungunya outbreaks: Stakeholder analysis’, PLOS Neglected Tropical Diseases, 18(4), p.e0012075. https://doi.org/10.1371/journal.pntd.0012075.
Maure, C., Khazhidinov, K., Kang, H., Auzenbergs, M., Moyersoen, P., Abbas, K., Santos, G.M.L., Medina, L.M.H., Wartel, T.A., Kim, J.H., Clemens, J. and Sahastrabuddhe, S. (2024) ‘Chikungunya vaccine development, challenges, and pathway toward public health impact’, Vaccine, 42(26), p.126483. https://doi.org/10.1016/j.vaccine.2024.126483.